MedPath

Biopsy results of the focal lesion detect by the artificial intelligence program for prostate MRI

Not Applicable
Active, not recruiting
Conditions
Neoplasms
Registration Number
KCT0006947
Lead Sponsor
The Catholic University of Korea, Eunpyeong St. Mary's Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
Male
Target Recruitment
208
Inclusion Criteria

1) Adults over 19 years old.
2) Patients undergoing prostate MRI due to clinically suspected prostate cancer during the period after IRB approval to December 31, 2023.
3) A patient who performs prostate MRI in the institutions
4) Patients who are determined to perform biopsy due to abnormalities detected in the MRI by radiologists or patients who are strongly suspected of prostate cancer although prostate MRI showed no abnormalities.

Exclusion Criteria

1) 1.5-T MRI: image quality is low
2) MRI performed in patients already diagnosed with prostate cancer.
3) More than 120 days between MRI and prostate biopsy.
4) Patients who cannot understand the contents of the study due to cognitive impairment

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath